Genscript Biotech Corporation
General ticker "GNNSF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $4.0B (TTM average)
Genscript Biotech Corporation follows the US Stock Market performance with the rate: 5.1%.
Estimated limits based on current volatility of 0.0%: low 1.42$, high 1.42$
Short-term GNNSF quotes
Long-term GNNSF plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $839.53MM | $594.49MM | $960.95MM |
| Operating Expenses | $1,255.32MM | $585.20MM | $705.32MM |
| Operating Income | $-415.79MM | $9.28MM | $255.62MM |
| Non-Operating Income | $64.81MM | $-180.08MM | $-726.85MM |
| Interest Expense | $27.51MM | $8.03MM | $17.32MM |
| R&D Expense | $433.84MM | $53.79MM | $71.34MM |
| Income(Loss) | $-350.98MM | $-170.80MM | $-471.23MM |
| Taxes | $-4.14MM | $2.98MM | $61.96MM |
| Profit(Loss)* | $-95.48MM | $2,961.88MM | $-533.62MM |
| Stockholders Equity | $1,391.08MM | $4,321.17MM | $3,958.81MM |
| Inventory | $53.35MM | $31.08MM | $39.59MM |
| Assets | $3,387.30MM | $5,278.27MM | $4,852.64MM |
| Operating Cash Flow | $-286.91MM | $75.65MM | $325.52MM |
| Capital expenditure | $157.71MM | $147.92MM | $83.84MM |
| Investing Cash Flow | $-357.73MM | $-1,456.36MM | $-171.95MM |
| Financing Cash Flow | $1,068.26MM | $66.52MM | $-144.89MM |
| Earnings Per Share** | $-0.05 | $1.40 | $-0.25 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.